Zobrazeno 1 - 10
of 114
pro vyhledávání: '"Yutaka Harano"'
Autor:
Yutaka Harano
Publikováno v:
Diabetes. 69
Adequate insulin action (sensitivity: IS) in muscle, liver and WB is the most important metabolic factor in diabetes, especially in S-GLUT-2 user. Oral intake of hypoglycemic agents followed by the standard 75g starch including 15% maltose (OSC, Sara
Autor:
Mitsuyoshi Namba, Masaru Tokuda, Etsuko Nagai, Yoshiki Kusunoki, Tomoyuki Katsuno, Kosuke Konishi, Kazuki Murai, Toshihiro Matsuo, Humihiro Ochi, Masayuki Miuchi, Yutaka Harano, Tomoya Hamaguchi, Aya Maeda, Jun-ichiro Miyagawa
Publikováno v:
Journal of Diabetes Investigation
Aims/Introduction Incretins might play some pathophysiological role in glucose metabolism in diabetes and obesity; it is not clear whether or not the amount and the pattern of incretin secretion vary with different types of sugars. To evaluate the ef
Publikováno v:
Arzneimittelforschung. 49:30-34
This study was conducted to know the effect of carbohydrate intake on serum 3,5,3'-triiodothyronine (CAS 6893-02-3, T3)-response to glucose ingestion and its relation to glucose tolerance in lean non-insulin-dependent diabetes mellitus (NIDDM) patien
Publikováno v:
Diabetes Research and Clinical Practice. 76:12-17
Endothelial dysfunction is regarded as an early stage of atherosclerosis, and plays a role in the development of atherosclerotic diseases. Insulin resistance is related to the atherosclerotic process. In this study, we examined the association betwee
Autor:
Munetake Kanda, Masaaki Suzuki, Yoichi Goto, Hiroshi Nonogi, Yutaka Harano, Shunichi Miyazaki, Satoshi Yasuda
Publikováno v:
European Heart Journal. 27:1159-1165
Aims Vascular endothelium is a major organ involved in hyperglycaemia and is affected by plasma asymmetric dimethylarginine (ADMA). ADMA is an endogenous, competitive inhibitor of nitric oxide synthase and is induced by inflammatory cytokines of tumo
Publikováno v:
American Journal of Hypertension. 15:927-931
Background Nifedipine has been reported to cause impairment of insulin sensitivity. But recently a controlled-released formulation of nifedipine (nifedipine-GITS) has been reported that it could improve insulin sensitivity. Methods We evaluated insul
Autor:
Y Kimura, Masaaki Suzuki, O Murase, M Takeuchi, Hideki Ito, Y Yamazaki, Y Hattori, Hajime Orimo, H Inada, Hajime Nawata, Yutaka Harano
Publikováno v:
Journal of Diabetes and its Complications. 16:115-118
Using cross-sectional and prospective analyses, the risk factors for macroangiopathy (MA) in nonobese Type 2 diabetic patients were evaluated. In the cross-sectional study, we determined a cutoff point for each variable at which changes in the preval
Autor:
Kazutaka Suzuki, Yutaka Harano, Munetake Kanda, Yuko Koyama, Satoshi Yasuda, Masaaki Suzuki, Itaru Takamizawa
Publikováno v:
Journal of Diabetes and its Complications. 16:19-23
Insulin resistance and hyperinsulinemia have been observed in over 70% of the nonobese, nondiabetic subjects with essential hypertension (HT). Alpha-1 blockers, ACE-antagonists, long-acting Ca blockers including nifedipine CR, some form of β-blocker
Autor:
Yuko Kimura, Makoto Takeuchi, Yutaka Harano, Akio Kanazawa, Kenichi Kodama, Kayoko Ryomoto, M. Hasegawa, Masaaki Suzuki, Yuichi Hattori
Publikováno v:
Endocrine Journal. 47:535-542
The correlation between various factors obtained during oral glucose tolerance tests (OGTT) and insulin sensitivity tests (steady state plasma glucose, SSPG method) were analyzed in non-diabetic subjects by Pearson's simple correlation. Similar data
Autor:
Yutaka Harano, Masaaki Suzuki, Hideki Koh, Setsu Ohara, Yasuko Nishioeda, Nobuyoshi Hirose, Motoo Tsushima
Publikováno v:
The Journal of Japan Atherosclerosis Society. 28:17-22